Challenges in the Diagnosis and Management of Newborns of COVID-19 Positive Mothers
Sufia Athar1*, Sarfraz Abedin2 and Wasim Lodhi3
1Specialist Obstetrics and Gynecology, Al-Wakra Hospital, HMC, Qatar
2Specialist NICU, Pediatric, Al-Wakra Hospital, HMC, Qatar
3Consultant Obstetrics and Gynecology, North Middlesex University Hospital, London, UK
*Corresponding Author: Sufia Athar, Specialist Obstetrics and Gynecology, Al-Wakra Hospital, HMC, Qatar.
July 13, 2021; Published: July 26, 2021
Coronavirus disease (COVID-19) pandemic has affected every nook and crook of the world. With the second and the impending third wave, the situation has further deteriorated. Neonates, being the vulnerable section of society, need more vigilance. With current recommendations, newborns of the infected mothers are being tested at birth. Considering the false-negative results of SARS-CoV-2, RT-PCR in children, neonates are liable to have higher false-negative results. Newer studies have revealed that neonates may develop the symptoms even after 5 - 21 days of birth. This may lead to delays in the diagnosis and the possibility of transmission of the disease to the caregivers. In this review, the current challenges in the diagnosis and management protocols of neonates are discussed, lightening the importance and protection for caregivers.
Keywords: Coronavirus Disease (COVID-19); SARS-CoV-2; RT-PCR
- World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard (2021).
- Centers for Disease Control and Prevention. “Evaluation and Management Considerations for Neonates at risk for COVID-19” (2021).
- Ludvigsson JF. “Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults”. Acta Paediatrics 109 (2020): 1088-1095.
- “Evaluation and Management Considerations for Neonates At Risk for COVID-19”. CDC (2020).
- Trevisanuto D., et al. “Coronavirus infection in neonates: a systematic review”. Archives of Disease in Childhood - Fetal and Neonatal Edition 106 (2021): 330-335.
- Juan J., et al. “Effect of coronavirus disease 2019 (COVID‐19) on maternal, perinatal and neonatal outcome: systematic review”. Ultrasound in Obstetrics and Gynecology 56 (2020): 15-27.
- Mullins E., et al. “Pregnancy and neonatal outcomes of COVID‐19: co-reporting of common outcomes from PAN‐COVID and AAP‐SONPM registries”. Ultrasound in Obstetrics and Gynecology 57 (2021): 573-581.
- Villar J., et al. “Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study”. JAMA Pediatrics (2021).
- Algarroba GN., et al. “Visualization of SARS-CoV-2 virus invading the human placenta using electron microscopy”. American Journal of Obstetrics and Gynecology2 (2020): 275-278.
- Ng WF., et al. “The placentas of patients with severe acute respiratory syndrome: a pathophysiological evaluation”. Pathology 38 (2006): 210-218.
- Li M., et al. “The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study”. PLoS ONE 15 (2020): e0230295.
- Blumberg DA., et al. “Vertical Transmission of SARS-CoV-2: What is the Optimal Definition?” The American Journal of Perinatology 37 (2020): 769-772.
- Vivanti AJ., et al. “Trans-placental transmission of SARS-CoV-2 infection”. Nature Communications 11 (2020): 3572.
- Solís-García G., et al. “Epidemiología, manejoyriesgodetransmisiónde SARS-CoV-2 enunacohortedehijosdemadresafectasde COVID-19”. Anales de Pediatría 94 (2021): 173-177.
- Laws RL., et al. “Symptoms and Transmission of SARS-CoV-2 Among Children — Utah and Wisconsin”. Pediatrics1 (2021): e2020027268.
- Posfay-Barbe KM., et al. “COVID-19 in children and the dynamics of infection in families”. Pediatrics2 (2020): e20201576.
- González-Donapetry P., et al. “SARS-CoV-2 Working Group. Think of the Children: Evaluation of SARS-CoV-2 Rapid Antigen Test in Pediatric Population”. The Pediatric Infectious Disease Journal5 (2021): 385-388.
- Di Pietro GM., et al. “Diagnosis of SARS-CoV-2 in children: accuracy of nasopharyngeal swab compared to nasopharyngeal aspirate”. European Journal of Clinical Microbiology and Infectious Diseases 40 (2021): 1155-1160.
- Pagani G., et al. “Seroprevalence of SARS-CoV-2 IgG significantly varies with age: results from a mass population screening (SARS-2-SCREEN-CdA)”. Med Rxiv (2020).
- Winichakoon P., et al. “Negative nasopharyngeal and oropharyngeal swabs do not rule out COVID-19”. Journal of Clinical Microbiology 58 (2020): e00297-e00220.
- Memish ZA., et al. “Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome”. The Journal of Infectious Diseases 210 (2014): 1590-1594.
- Xing YH., et al. “Prolonged viral shedding in feces of pediatric patients with coronavirus disease”. Journal of Microbiology, Immunology and Infection 53 (2019): 473-480.
- Li X., et al. “The role of children in transmission of SARS-CoV-2: A rapid review”. Journal of Global Health 10 (2020): 011101.
- Widders A., et al. “SARS-CoV-2: the viral shedding vs infectivity dilemma”. Infection, Disease and Health3 (2020): 210-215.
- Liu P., et al. “Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19”. Emerging Microbes and Infections 9 (2020): 1254-1258.
- Guo M., et al. “Potential intestinal infection and faecal-oral transmission of SARS-CoV-2”. Nature Reviews Gastroenterology and Hepatology 18 (2021): 269-283.